you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Jan 15, 16:00
5210.00 -99.95 (-1.88%)
Volume
AVERAGE VOLUME
5-Day
27,129
10-Day
27,303
30-Day
39,078
17,903
  • Prev. Close

    5309.95

  • Open Price

    5309.95

  • Bid Price (Qty.)

    5207.60 (20)

  • Offer Price (Qty.)

    5210.00 (1)

NSE Live

Jan 15, 16:01
5212.80 -96.10 (-1.81%)
Volume
AVERAGE VOLUME
5-Day
734,317
10-Day
718,947
30-Day
1,078,121
515,521
  • Prev. Close

    5308.90

  • Open Price

    5315.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    5212.80 (104)

Financials

2020 2019 2018 2017 2016
Profit & Loss account of Dr Reddys Laboratories (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 11,803.00 10,572.90 9,302.60 9,628.10 10,234.80  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 84.20  
Revenue From Operations [Net] 11,803.00 10,572.90 9,302.60 9,628.10 10,150.60  
Total Operating Revenues 11,850.40 10,625.50 9,359.30 9,719.80 10,207.70  
Other Income 743.20 238.40 204.00 591.20 244.80  
Total Revenue 12,593.60 10,863.90 9,563.30 10,311.00 10,452.50  
EXPENSES  
Cost Of Materials Consumed 2,556.50 2,103.20 2,011.00 1,904.60 1,988.50  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 94.20  
Changes In Inventories Of FG,WIP And Stock-In Trade -99.90 66.00 -51.60 1.90 -28.80  
Employee Benefit Expenses 2,030.20 1,931.90 1,843.00 1,803.30 1,710.00  
Finance Costs 47.80 56.80 62.80 57.20 63.80  
Depreciation And Amortisation Expenses 789.20 780.60 774.10 735.10 649.10  
Other Expenses 3,376.80 3,356.10 3,555.40 3,592.90 3,429.40  
Total Expenses 9,817.80 9,163.20 8,866.30 8,766.50 8,516.60  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 2,775.80 1,700.70 697.00 1,544.50 1,935.90  
Exceptional Items 0.00 0.00 0.00 0.00 -355.90  
Profit/Loss Before Tax 2,775.80 1,700.70 697.00 1,544.50 1,580.00  
Tax Expenses-Continued Operations  
Current Tax 483.90 281.80 138.10 182.60 416.00  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 97.00  
Deferred Tax -645.80 141.60 -8.00 -22.20 -93.50  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses -161.90 423.40 130.10 160.40 225.50  
Profit/Loss After Tax And Before ExtraOrdinary Items 2,937.70 1,277.30 566.90 1,384.10 1,354.50  
Profit/Loss From Continuing Operations 2,937.70 1,277.30 566.90 1,384.10 1,354.50  
Profit/Loss For The Period 2,937.70 1,277.30 566.90 1,384.10 1,354.50  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 177.23 76.98 34.19 83.05 79.42  
Diluted EPS (Rs.) 176.88 76.85 34.12 82.88 79.14  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 766.80  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 1,221.70  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 107.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 322.10  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 391.40 332.00 399.20 335.30 340.50  
Tax On Dividend 0.00 68.20 0.00 0.00 69.30  
Equity Dividend Rate (%) 500.00 400.00 400.00 400.00 400.00  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs